40.00
+0.91(+2.33%)
Currency In USD
Address
Building B15 and 25
Alajuela,
Costa Rica
Phone
506 2434 2400
Sector
Healthcare
Industry
Medical - Devices
Employees
1034
First IPO Date
July 19, 2018
| Name | Title | Pay | Year Born |
| Mr. Fillipo Peter Caldini | Chief Executive Officer | 441,643 | 1965 |
| Mr. Salvador Santos Dada | Head of Special Projects | 468,616 | 1983 |
| Mr. S. Ross Mansbach | General Counsel, Chief Compliance Officer & Chief Human Resources Officer | 528,806 | 1968 |
| Mr. Rajbir Singh Denhoy | Chief Financial Officer | 565,639 | 1971 |
| Mr. Juan Jose Chacon Quiros | Founder & Executive Director | 1.27M | 1973 |
| Mr. Roberto de Mezerville | Chief Technology Officer | 0 | 1981 |
| Mr. Ivan Bilic | Senior Vice President of Commercial Operations - OUS | 0 | N/A |
| Mr. Jeff Ehrhardt | Senior Vice President & GM of North America | 0 | N/A |
| Ms. Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical & US Regulatory Affairs | 0 | N/A |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.